PEN-866
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PEN-866, covering 2022-02-17 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]